Steroid sulfatase and estrogen sulfotransferase in human prostate cancer

Prostate

Volumn 66, Issue 9, 2006, Pages 1005-1012

  Nakamura, Yasuhiro ^a   Suzuki, Takashi ^a   Fukuda, Tsuyoshi ^a   Ito, Akihiro ^a   Endo, Mareyuki ^a   Moriya, Takuya ^a   Arai, Yoichi ^a   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cell lines; Estrogen sulfotransferase; Immunohistochemistry; Prostate cancer; Steroid sulfatase

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN SULFOTRANSFERASE; ESTRONE; MESSENGER RNA; STERYL SULFATASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER TISSUE; CELL STRAIN LNCAP; CONTROLLED STUDY; ESTROGEN METABOLISM; ESTROGEN SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION;

CELL LINE, TUMOR; ESTRADIOL; ESTRONE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROSTATIC NEOPLASMS; STERYL-SULFATASE; SULFOTRANSFERASES;

EID: 33744910575     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20426     Document Type: Article

References (21)

1. Lopez-Otin C, Diamandis EP. Breast and prostate cancer: An analysis of common epidemiological, genetic, and biochemical features. Endocr Rev 1998;19:365-396.
2. Nakamura Y, Suzuki T, Nakabayashi M, Endoh M, Sakamoto K, Mikami Y, Moriya T, Ito A, Takahashi S, Yamada S, Arai Y, Sasano H. In situ androgen producing enzymes in human prostate cancer. Endocr Relat Cancer 2005;12:101-107.
3. Harkonen PL, Makela SI. Role of estrogens in development of prostate cancer. J Steroid Biochem Mol Biol 2004;92:297-305.
4. Griffiths K. Estrogens and prostatic disease. International Prostate Health Council Study Group. Prostate 2000;45:87-100.
5. Ho SM. Estrogens and anti-estrogens: Key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 2004;91:491-503.
6. Koh E, Noda T, Kanaya J, Namiki M. Differential expression of 17beta-hydroxysteroid dehydrogenase isozyme genes in prostate cancer and noncancer tissues. Prostate 2002;53:154-159.
7. Nakamura Y, Miki Y, Suzuki T, Nakata T, Darnel AD, Moriya T, Tazawa C, Saito H, Ishibashi T, Takahashi S, Yamada S, Sasano H. Steroid sulfatase and estrogen sulfotransferase in the atherosclerotic human aorta. Am J Pathol 2003;163:1329-1339.
8. Falany CN. Enzymology of human cytosolic sulfotransferase. EMBO J 1997;11:206-216.
9. Dao TL, Hayes C, Liddy PR. Steroid sulfatase activities in human breast tumors. Proc Soc Exp Biol Med 1974;146:381-384.
10. Pasqualini JR, Gelly C, Lecerf F. Estrogen sulfatase: Biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. Breast Cancer Res Treat 1986;8:233-240.
11. Naitoh K, Honjo H, Yamamoto T, Urabe M, Ogino Y, Yasumura T, Nambara T. Estrone sulfatase and sulfotransferase activity in human breast cancer and endometrial cancer. J Steroid Biochem 1989;33:1049-1054.
12. Selcer KW, Kabler H, Sarap J, Xiao Z, Li PK. Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells. Steroids 2002;67:82l-826.
13. Klein H, Bressel M, Kastendieck H, Voigt KD. Quantitative assessment of endogenous testicular and adrenal sex steroids and of steroid metabolizing enzymes in untreated human prostatic cancerous tissue. J Steroid Biochem 1988;30:119-130.
14. Franz C, Watson D, Longcope C. Estrone sulfate and dehydroepiandrosterone sulfate concentrations in normal subjects and men with cirrhosis. Steroids 1979;34:563-573.
15. Wang C, Catlin DH, Starcevic B, Heber D, Ambler C, Berman N, Lucas G, Leung A, Schramm K, Lee PW, Hull L, Swerdloff RS. Low-fat high-fiber diet decreased serum and urine androgens in men. J Clin Endocrinol Metab 2005;90:3550-3559.
16. Santner SJ, Feil PD, Santen RJ. In situ estrogen production via the estrone sulfatase pathway in breast tumors: Relative importance versus the aromatase pathway. J Clin Endocrinol Metab 1984;59:29-33.
17. Maggiolini M, Recchia AG, Carpino A, Vivacqua A, Fasanella G, Rago V, Pezzi V, Briand PA, Picard D, Ando S. Oestrogen receptor beta is required for and rogen-stimulated proliferation of LNCaP prostate cancer cells. J Mol Endocrinol 2004;32:777-791.
18. Oduwole OO, Li Y, Isomaa VV, Mantyniemi A, Pulkka AE, Soini Y, Vihko PT. 17beta-hydroxysteroid dehydrogenase type 1 is an independent prognostic marker in breast cancer. Cancer Res 2004;64:7604-7609.
19. Horvath LG, Henshall SM, Lee CS, Head DR, Quinn DI, Makela S, Delprado W, Golovsky D, Brenner PC, O'Neill G, Kooner R, Stricker PD, Grygiel JJ, Gustafsson JA, Sutherland RL. Frequent loss of estrogen receptor-beta expression in prostate cancer. Cancer Res 2001;61:5331-5335.
20. Leav I, Lau KM, Adams JY, McNeal JE, Taplin ME, Wang J, Singh H, Ho SM. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol 2001;159:79-92.
21. Zhu X, Leav I, Leung YK, Wu M, Liu Q, Gao Y, McNeal JE, Ho SM. Dynamic regulation of estrogen receptor-beta expression by DNA methylation during prostate cancer development and metastasis. Am J Pathol 2004;164:2003-2012.